Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MAS receptor (MAS1) is a G protein-coupled receptor and a key component of the renin-angiotensin system (RAS). It is primarily activated by angiotensin-(1–7), leading to vasodilation, anti-inflammatory, anti-fibrotic, and anti-thrombotic effects. The MAS receptor acts as a counter-regulatory component within the RAS, opposing the actions of angiotensin II. Its broad tissue distribution suggests additional functions beyond blood pressure control, potentially including roles in behavior or metabolism.
Agonists activate the MAS receptor, leading to downstream signaling via Gαq, Gαi/s, and Gα12 proteins. This results in increased intracellular calcium, modulation of cAMP levels, and cytoskeletal rearrangement.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAS Receptor (MAS1).